{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:31:38Z","timestamp":1793406698689,"version":"4.5.0"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Information about longitudinal associations of attention-deficit\/hyperactivity disorder (ADHD) diagnosis, symptom severity, pharmacotherapy, and incident nicotine and tobacco use, including e-cigarettes, among US youths is limited.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate whether ADHD diagnosis, symptom severity, and pharmacotherapy are associated with incident e-cigarette and tobacco use over a 9-year period.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This longitudinal cohort study followed up a nationally representative sample of US youths and their parents in the Population Assessment of Tobacco and Study via questionnaires from wave 1 (September 2013 to December 2014) to waves 2 to 7 (October 2014 to April 2023). Participants were representative of the US civilian noninstitutionalized population. Youths aged 12 to 17 years at wave 1 (N\u2009=\u200913\u202f572) and their parents were interviewed.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Time in years and history of ADHD diagnosis, symptom severity, and pharmacotherapy at wave 1 were used to construct 9 mutually exclusive subgroups of US youths, including those with ADHD diagnosis and pharmacotherapy, ADHD diagnosis without pharmacotherapy, and population controls without ADHD diagnosis; within each of these 3 subgroups, ADHD symptom severity was categorized as none, 1 to 2, or 3 to 4 symptoms.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Incident e-cigarette use, cigarette smoking, other tobacco use, and dual use (e-cigarette and cigarette and\/or other tobacco use) in weighted percentages with 95% CIs.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 13 572 youths included in the analysis, 6967 (51.3%; 95% CI, 51.2%-51.5%) were male. An estimated 1881 participants (14.1%; 95% CI,\u200913.2%-15.0%) were diagnosed with ADHD. Multivariable logistic regression analyses indicated that the adjusted odds of incident e-cigarette use, cigarette smoking, other tobacco use, and dual use did not significantly differ between those with asymptomatic ADHD (with or without pharmacotherapy) compared with population controls. In contrast, all subgroups who had 3 or more ADHD symptoms (with or without pharmacotherapy) had significantly higher adjusted odds of e-cigarette use (adjusted odds ratio [AOR],\u20091.60; 95% CI,\u20091.34-2.04), cigarette smoking (AOR,\u20091.52; 95% CI,\u20091.22-1.89), other tobacco use (AOR,\u20091.61; 95% CI,\u20091.27-2.02), and dual use (AOR,\u20091.72; 95% CI,\u20091.38-2.14) compared with youths with asymptomatic ADHD or population controls. Among youths with ADHD, those with highly symptomatic ADHD were significantly more likely to initiate e-cigarette (AOR, 1.68; 95% CI, 1.16-2.44) and dual use (AOR, 1.82; 95% CI, 1.17-2.83) than youths without symptoms.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort study of US youths, ADHD symptoms were associated with the onset of nicotine and tobacco use. Findings highlight the importance of early diagnosis and effective treatment of ADHD to alleviate symptoms and reduce the risk of later nicotine and tobacco use.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.58834","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:04:28Z","timestamp":1739289868000},"page":"e2458834","source":"Crossref","is-referenced-by-count":11,"title":["Attention-Deficit\/Hyperactivity Disorder Symptoms and Later E-Cigarette and Tobacco Use in US Youths"],"prefix":"10.1001","volume":"8","author":[{"given":"Sean Esteban","family":"McCabe","sequence":"first","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor"},{"name":"Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor"},{"name":"Institute for Research on Women and Gender, University of Michigan, Ann Arbor"},{"name":"Department of Health Behavior and Clinical Sciences, School of Nursing, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Pasman","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor"},{"name":"Department of Health Behavior and Clinical Sciences, School of Nursing, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Wilens","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor"},{"name":"Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Boyd","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor"},{"name":"Institute for Research on Women and Gender, University of Michigan, Ann Arbor"},{"name":"Department of Health Behavior and Clinical Sciences, School of Nursing, University of Michigan, Ann Arbor"},{"name":"Department of Psychiatry, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Veliz","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor"},{"name":"Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor"},{"name":"Institute for Research on Women and Gender, University of Michigan, Ann Arbor"},{"name":"Department of Systems, Populations and Leadership, University of Michigan, Ann Arbor"},{"name":"Applied Biostatistical Laboratory, School of Nursing, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"McCabe","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor"},{"name":"Department of Psychiatry, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Applied Biostatistical Laboratory, School of Nursing, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Evans-Polce","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor"},{"name":"Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor"},{"name":"Department of Health Behavior and Clinical Sciences, School of Nursing, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"5","key":"zoi241644r3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.amepre.2023.12.017","article-title":"New estimates of smoking-attributable mortality in the U.S. from 2020 through 2035.","volume":"66","author":"Le","year":"2024","journal-title":"Am J Prev Med"},{"issue":"1","key":"zoi241644r4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jaac.2010.09.019","article-title":"Childhood attention-deficit\/hyperactivity disorder and future substance use disorders: comparative meta-analyses.","volume":"50","author":"Charach","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"zoi241644r5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10802-011-9575-6","article-title":"The effects of childhood ADHD symptoms on early-onset substance use: a Swedish twin study.","volume":"40","author":"Chang","year":"2012","journal-title":"J Abnorm Child Psychol"},{"issue":"8","key":"zoi241644r6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/add.12188","article-title":"Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.","volume":"108","author":"Groenman","year":"2013","journal-title":"Addiction"},{"issue":"3","key":"zoi241644r7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jpeds.2008.04.030","article-title":"Cigarette smoking associated with attention deficit hyperactivity disorder.","volume":"153","author":"Wilens","year":"2008","journal-title":"J Pediatr"},{"issue":"10","key":"zoi241644r8","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/archpsyc.62.10.1142","article-title":"Association between smoking and attention-deficit\/hyperactivity disorder symptoms in a population-based sample of young adults.","volume":"62","author":"Kollins","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"zoi241644r9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1089\/cap.2005.15.799","article-title":"Attention-deficit\/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults.","volume":"15","author":"Upadhyaya","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"zoi241644r10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/00004583-200207000-00011","article-title":"Association of attention-deficit\/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents.","volume":"41","author":"Tercyak","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"zoi241644r11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.drugalcdep.2004.10.003","article-title":"Childhood hyperactivity-inattention symptoms and smoking in adolescence.","volume":"78","author":"Gal\u00e9ra","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"zoi241644r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101524","article-title":"Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: an observational cohort study.","volume":"50","author":"Brumbaugh","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"3","key":"zoi241644r13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/15374416.2024.2335625","article-title":"ADHD prevalence among U.S. children and adolescents in 2022: diagnosis, severity, co-occurring disorders, and treatment.","volume":"53","author":"Danielson","year":"2024","journal-title":"J Clin Child Adolesc Psychol"},{"key":"zoi241644r15","doi-asserted-by":"publisher","DOI":"10.1136\/tc-2022-057907","article-title":"Declines in cigarette smoking among US adolescents and young adults: indications of independence from e-cigarette vaping surge.","author":"Pierce","journal-title":"Tob Control"},{"issue":"1","key":"zoi241644r16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12887-017-0971-0","article-title":"Challenges in defining the rates of ADHD diagnosis and treatment: trends over the last decade.","volume":"17","author":"Davidovitch","year":"2017","journal-title":"BMC Pediatr"},{"issue":"11","key":"zoi241644r17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.14344","article-title":"Trends in the prevalence and incidence of attention-deficit\/hyperactivity disorder among adults and children of different racial and ethnic groups.","volume":"2","author":"Chung","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi241644r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.36872","article-title":"Prevalence and trends in diagnosed adhd among US children and adolescents, 2017-2022.","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Netw Open"},{"key":"zoi241644r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.07.009","article-title":"Is cigarette smoking a gateway drug to subsequent alcohol and illicit drug use disorders: a controlled study of youth with and without ADHD.","author":"Biederman","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1-2","key":"zoi241644r20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0006-8993(00)02823-7","article-title":"Persistent and delayed behavioral changes after nicotine treatment in adolescent rats.","volume":"880","author":"Trauth","year":"2000","journal-title":"Brain Res"},{"issue":"2","key":"zoi241644r21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jaac.2010.11.010","article-title":"Do executive function deficits predict later substance use disorders among adolescents and young adults?","volume":"50","author":"Wilens","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"zoi241644r22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S1355617702801345","article-title":"Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning.","volume":"8","author":"Barkley","year":"2002","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"zoi241644r23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.4174","article-title":"Serious transport accidents in adults with attention-deficit\/hyperactivity disorder and the effect of medication: a population-based study.","volume":"71","author":"Chang","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"zoi241644r24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/tobaccocontrol-2016-052934","article-title":"Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.","volume":"26","author":"Hyland","year":"2017","journal-title":"Tob Control"},{"issue":"suppl 1","key":"zoi241644r26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/10550490601006055","article-title":"Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime\/violence problems among adolescents and adults.","volume":"15","author":"Dennis","year":"2006","journal-title":"Am J Addict"},{"issue":"6","key":"zoi241644r27","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.amepre.2023.01.017","article-title":"Sexual identity differences in tobacco (re)uptake: testing mediation by internalizing and externalizing symptoms.","volume":"64","author":"Evans-Polce","year":"2023","journal-title":"Am J Prev Med"},{"issue":"3","key":"zoi241644r29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0407","article-title":"Racial and ethnic disparities in ADHD diagnosis and treatment.","volume":"138","author":"Coker","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"zoi241644r30","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/ntr\/nts344","article-title":"Race\/ethnicity, nativity, and tobacco use among US young adults: results from a nationally representative survey.","volume":"15","author":"Lariscy","year":"2013","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"zoi241644r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0321","article-title":"Racial disparities in diagnosis of attention-deficit\/hyperactivity disorder in a US national birth cohort.","volume":"4","author":"Shi","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi241644r34","first-page":"155","article-title":"It\u2019s about time: using discrete-time survival analysis to study duration and the timing of events.","volume":"18","author":"Singer","year":"1993","journal-title":"J Educ Stat"},{"issue":"1","key":"zoi241644r35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12874-022-01679-6","article-title":"Survival prediction models: an introduction to discrete-time modeling.","volume":"22","author":"Suresh","year":"2022","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"zoi241644r36","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.bcp.2007.07.002","article-title":"Neuronal nicotinic receptor agonists for the treatment of attention-deficit\/hyperactivity disorder: focus on cognition.","volume":"74","author":"Wilens","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"zoi241644r37","first-page":"661","article-title":"Tobacco smoking in individuals with attention-deficit hyperactivity disorder: epidemiology and pharmacological approaches to cessation.","volume":"23","author":"Gray","year":"2009","journal-title":"CNS Drugs"},{"issue":"4","key":"zoi241644r38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/14622200801979019","article-title":"Smoking is associated with lower performance in WAIS-R Block Design scores in adults with ADHD.","volume":"10","author":"Kalil","year":"2008","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"zoi241644r39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1469-7610.2008.01960.x","article-title":"Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo.","volume":"50","author":"Buitelaar","year":"2009","journal-title":"J Child Psychol Psychiatry"},{"issue":"3","key":"zoi241644r40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jaac.2021.05.019","article-title":"Review: adult outcome as seen through controlled prospective follow-up studies of children with attention-deficit\/hyperactivity disorder followed into adulthood.","volume":"61","author":"Cherkasova","year":"2022","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"zoi241644r41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/CHI.0b013e31819c23d0","article-title":"The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.","volume":"48","author":"Molina","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"18","key":"zoi241644r42","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.12998\/wjcc.v11.i18.4267","article-title":"Multimodal integrated intervention for children with attention-deficit\/hyperactivity disorder.","volume":"11","author":"Lv","year":"2023","journal-title":"World J Clin Cases"},{"issue":"3","key":"zoi241644r43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.brat.2011.01.001","article-title":"Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial.","volume":"49","author":"Hirvikoski","year":"2011","journal-title":"Behav Res Ther"},{"issue":"2","key":"zoi241644r44","first-page":"82","article-title":"Reliability and concurrent validity of the GAIN Short Screener among youth utilizing integrated health services.","volume":"30","author":"Khanano","year":"2021","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"1","key":"zoi241644r45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.54566","article-title":"Tobacco, alcohol, cannabis, and other drug use in the US before and during the early phase of the COVID-19 pandemic.","volume":"6","author":"Compton","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi241644r46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12888-024-05623-4","article-title":"ADHD prescription patterns and medication adherence in children and adolescents during the COVID-19 pandemic in an urban academic setting.","volume":"24","author":"Cunniff","year":"2024","journal-title":"BMC Psychiatry"},{"key":"zoi241644r47","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.3368\/jhr.1222-12708R2","article-title":"Societal disruptions and childhood ADHD diagnosis during the COVID-19 pandemic.","volume":"59","author":"Freedman","year":"2024","journal-title":"J Hum Resour"},{"issue":"6","key":"zoi241644r48","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00787-023-02148-1","article-title":"Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic.","volume":"32","author":"Santosh","year":"2023","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"zoi241644r1","unstructured":"The health consequences of smoking\u201450 years of progress: a report of the Surgeon General. US Dept of Health and Human Services. 2014. Accessed July 29, 2024. https:\/\/stacks.cdc.gov\/view\/cdc\/21569"},{"key":"zoi241644r2","unstructured":"Smoking cessation: a report of the surgeon general. United States Public Health Service Office of the Surgeon General. 2020. Accessed October 9, 2024. https:\/\/pubmed.ncbi.nlm.nih.gov\/32255575\/?"},{"key":"zoi241644r14","unstructured":"Miech? RA, Johnston? LD, Patrick? ME, O\u2019Malley? PM, Bachman? JG, Schulenberg? JE. Monitoring the Future: national survey results on drug use, 1975\u20132022: secondary school students. 2023. Accessed March 3, 2024. https:\/\/monitoringthefuture.org\/wp-content\/uploads\/2022\/12\/mtf2022.pdf"},{"key":"zoi241644r25","unstructured":"Population Assessment of Tobacco and Health (PATH) Study [United States] restricted-use files (ICPSR 36231). National Addiction & HIV Data Archive Program. October 11, 2024. Accessed October 11, 2024. https:\/\/www.icpsr.umich.edu\/web\/NAHDAP\/studies\/36231?"},{"key":"zoi241644r28","unstructured":"PhenX Toolkit. Protocol: attention-deficit hyperactivity disorder symptoms\u2014child. 2024. Accessed October 9, 2024. https:\/\/www.phenxtoolkit.org\/protocols\/view\/121502"},{"key":"zoi241644r31","unstructured":"Miech? RA, Johnston? LD, Patrick? ME, O\u2019Malley? PM. Monitoring the Future national survey results on drug use, 1975-2023: overview and detailed results for secondary school students. Institute for Social Research, University of Michigan. 2024. Accessed October 9, 2024. https:\/\/monitoringthefuture.org\/wp-content\/uploads\/2024\/01\/mtfoverview2024.pdf"},{"key":"zoi241644r32","doi-asserted-by":"crossref","unstructured":"Patrick? ME, Miech? RA, Johnston? LD, O\u2019Malley? PM. Monitoring the Future Panel Study annual report: national data on substance use among adults ages 19 to 65, 1976\u20132023. Institute for Social Research, University of Michigan. 2024. Accessed October 9, 2024. https:\/\/monitoringthefuture.org\/wp-content\/uploads\/2024\/07\/mtfpanel2024.pdf","DOI":"10.7826\/ISR-UM.06.585140.002.07.0002.2023"},{"key":"zoi241644r49","unstructured":"FDA announces shortage of Adderall. US Food and Drug Administration. August 1, 2023. Accessed July 9, 2024. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-announces-shortage-adderall?os=rokuZoazxZMs&ref=app"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2830092\/mccabe_2025_oi_241644_1738355168.55398.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:04:42Z","timestamp":1739289882000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2830092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.58834","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]}}}